Stocks UP and Stocks DOWN

Posted on April 14, 2025 by Dr. David Edward Marcinko MBA MEd CMP™

By Staff Reporters

***

***

🟢 What’s up

  • Auto stocks soared on comments from President Trump that car companies “need a little bit of time.” GM rose 3.48%, Ford climbed 4.13%, and Stellantis gained 5.64%.
  • Investors are bullish: WeBull exploded 374.72% after the online investment platform went public via SPAC merger last Friday.
  • Goldman Sachs rose 1.87% after the Wall Street titan announced record revenue in its equities-trading business thanks to stock market volatility in the first quarter.
  • Palantir gained 4.60% after it sealed a deal with NATO to provide the organization with its advanced AI-powered warfighting system.
  • Intel climbed 2.89% on news that it will sell a 51% stake in its programmable chips unit Altera to Silver Lake Management.
  • Pfizer somehow rose 0.96% despite announcing that it is discontinuing the development of a once-daily weight-loss pill after a patient experienced a liver injury. That’s great news for Viking Therapeutics, which has its own oral weight-loss pill in the pipeline. Shares of Viking rose 10.58%.
  • Speaking of biotech stocks, Verve Therapeutics soared 26.38% after the company reported no issues with patients trialing its new gene-editing technology.

What’s down

  • Meta Platforms fell 2.22% as its antitrust trial began today. If it loses its case against the FTC, it may be forced to sell off Instagram.
  • DaVita sank 3.03% after the kidney disease treatment company announced it was the victim of a ransomware attack.
  • Hilton Worldwide Holdings fell 1.10% on a downgrade from Goldman Sachs analysts, who believe the vacation club company will struggle as fewer people splurge on travel. Marriott International received the same treatment, and also dropped 0.77%.
  • LVMH Moet Hennessy Louis Vuitton (really rolls off the tongue) tumbled 6.39% after the luxury goods retailer missed analyst expectations, reporting a 3% decline in sales compared to forecasts of 2% growth.
  • It’s a bit broad, but Citi analysts downgraded all US stocks to “neutral” this morning. The analysts argued that US stocks are too exposed to President Trump’s policies and are expensive compared to international peers, and endorsed investing in Japanese, European, and UK equities instead.

COMMENTS APPRECIATED

Like and Refer

***

***

Filed under: "Ask-an-Advisor", Financial Planning, Health Economics, Information Technology, Investing | Tagged: , , , , , , , , , , , , | Leave a comment »

DAILY UPDATE: DaVita Down and NASDAQ Up

Posted on February 15, 2025 by Dr. David Edward Marcinko MBA MEd CMP™

MEDICAL EXECUTIVE-POST – TODAY’S NEWSLETTER BRIEFING

***

Essays, Opinions and Curated News in Health Economics, Investing, Business, Management and Financial Planning for Physician Entrepreneurs and their Savvy Advisors and Consultants

“Serving Almost One Million Doctors, Financial Advisors and Medical Management Consultants Daily“

A Partner of the Institute of Medical Business Advisors , Inc.

http://www.MedicalBusinessAdvisors.com

SPONSORED BY: Marcinko & Associates, Inc.

***

http://www.MarcinkoAssociates.com

Daily Update Provided By Staff Reporters Since 2007.
How May We Serve You?
© Copyright Institute of Medical Business Advisors, Inc. All rights reserved. 2025

REFER A COLLEAGUE: MarcinkoAdvisors@outlook.com

SPONSORSHIPS AVAILABLE: https://medicalexecutivepost.com/sponsors/

ADVERTISE ON THE ME-P: https://tinyurl.com/ytb5955z

Your Referral Count -0-

CITE: https://www.r2library.com/Resource

Although Berkshire-Hathaway sold 203,091 shares on Friday, it still owns 45 percent of DaVita, Inc.  The stake, valued at $6.4 billion, has been part of Berkshire’s portfolio since 2011. The sell-off Friday was after the sale was disclosed to Wall Street after markers closed on Thursday. When Wall Street shut at 4pm in New York, DaVita was down 11.1 percent –  the stock’s biggest one-day selloff in almost two years for the kidney dialysis provider company.

CITE: https://tinyurl.com/2h47urt5

The S&P 500 barely budged and slipped by less than 0.1%, a day after rallying within 0.1% of its record set last month. The Dow Jones Industrial Average dipped 165 points, or 0.4%, while the NASDAQ composite rose 0.4%.

CITE: https://tinyurl.com/tj8smmes

Visualize: How private equity tangled banks in a web of debt, from the Financial Times.

COMMENTS APPRECIATED

PLEASE SUBSCRIBE: MarcinkoAdvisors@outlook.com

Thank You

***

***

***

***

EDUCATIONAL TEXTBOOKS: https://tinyurl.com/4zdxuuwf

***

Filed under: Financial Planning, Funding Basics, Information Technology, Investing, Recommended Books, Sponsors | Tagged: , , , , , , , , , , , | Leave a comment »

DAILY UPDATE: Ardent Health IPO, Davita Settles, Amex Reports with Choppy Stock Markets

Posted on July 24, 2024 by Dr. David Edward Marcinko MBA MEd CMP™

MEDICAL EXECUTIVE-POST – TODAY’S NEWSLETTER BRIEFING

***

Essays, Opinions and Curated News in Health Economics, Investing, Business, Management and Financial Planning for Physician Entrepreneurs and their Savvy Advisors and Consultants

“Serving Almost One Million Doctors, Financial Advisors and Medical Management Consultants Daily“

A Partner of the Institute of Medical Business Advisors , Inc.

http://www.MedicalBusinessAdvisors.com

SPONSORED BY: Marcinko & Associates, Inc.

***

http://www.MarcinkoAssociates.com

Daily Update Provided By Staff Reporters Since 2007.
How May We Serve You?
© Copyright Institute of Medical Business Advisors, Inc. All rights reserved. 2024

REFER A COLLEAGUE: MarcinkoAdvisors@msn.com

SPONSORSHIPS AVAILABLE: https://medicalexecutivepost.com/sponsors/

ADVERTISE ON THE ME-P: https://tinyurl.com/ytb5955z

***

Stat: 13%. That’s how much millennial and Gen Z spending increased year over year, according to American Express earnings released last week. Amex reported slower growth in travel and entertainment compared to the previous quarter, but restaurant spending “remained strong.” (PYMNTS)

CITE: https://www.r2library.com/Resource

Here’s where the major stock market benchmarks ended:

  • The S&P 500 fell about 9 points (0.16%) to 5,555.69; the Dow Jones Industrial Average shed 57 points (0.14%) to 40,358.09; the NASDAQ Composite ($COMP) ended 10 points lower (0.06%) at 17,997.35.
  • The 10-year Treasury note yield (TNX) was unchanged at 4.255%.
  • The CBOE Volatility Index® (VIX) decreased about 2% to 14.62.

What’s up

What’s down

  • UPS delivered a 12.05% dip, falling to new all-time lows after missing analyst earnings expectations, as well as cutting its revenue forecast.
  • NXP Semiconductors plunged 7.58% on management’s poor revenue forecast for the coming quarter, despite meeting expectations this quarter.
  • Comcast sank 2.58% on a mixed earnings announcement that saw the company beat on earnings but miss revenue thanks to a slow theme parks segment.
  • GM stalled 6.43% despite announcing solid earnings—investors didn’t like to hear management note that the second half of the year will be a lot tougher.

CITE: https://tinyurl.com/2h47urt5

Kidney care giant DaVita has agreed to pay nearly $34.5 million to settle allegations that it paid kickbacks for referrals to its former DavitaRx subsidary.

And … Ardent Health was targeting a $300 million IPO but raised just $192 million.

CITE: https://tinyurl.com/tj8smmes

COMMENTS APPRECIATED

PLEASE SUBSCRIBE: MarcinkoAdvisors@msn.com

Thank You

***

***

***

***

EDUCATIONAL TEXTBOOKS: https://tinyurl.com/4zdxuuwf

***

Filed under: "Ask-an-Advisor", Breaking News, Drugs and Pharma, Ethics, Experts Invited, Financial Planning, Health Economics, Health Insurance, Information Technology, Investing, Marcinko Associates | Tagged: , , , , , , , , , , , , , | Leave a comment »

EARNINGS SEASON: Consumer Spending

Posted on October 12, 2023 by Dr. David Edward Marcinko MBA MEd CMP™

By Staff Reporters

***

***

  • Markets: Stocks notched their fourth winning day in a row yesterday as investors digested the news that the Fed was split about future rate hikes at its last meeting while waiting for this morning’s report on how much consumer prices rose last month.
  • Ozempic continues eating into investors’ appetites for other industries. Its maker, Novo Nordisk, rose on the news that the diabetes drug may help treat kidney failure, but dialysis providers DaVita and Fresenius Medical Care plunged.

***

Earnings season is back: PepsiCo, Delta, Dominos, and big banks headline the start of earnings season, one that will have investors looking at how slowing inflation has affected the ability of companies to pad their profit margins. Pepsi’s report will be closely watched as its snack division, Frito-Lay, could be tested by the increasing popularity of weight-loss drugs like Wegovy. Major banks like JPMorgan are expected to post strong results.

CITE: https://www.r2library.com/Resource

US consumer spending: Has remained surprisingly strong despite rising interest rates, and a senior spending spree could explain it. According to the Department of Labor, Americans aged 65 and older accounted for 22% of consumer spending last year, the highest percentage since records began in 1972. It also helps that 17.7% of the US population is 65 and older, the highest on record dating to 1920. Better health, longer lifespans, and changes in attitude toward saving for a rainy day after the pandemic have boomers feeling OK about their finances.

COMMENTS APPRECIATED

Thank You

***

***

Filed under: "Ask-an-Advisor", Drugs and Pharma, Events-Planner, Funding Basics, Investing | Tagged: , , , , , , , , , | Leave a comment »

ORGAN TRANSPLANTS: Overhauling the System

Posted on March 24, 2023 by Dr. David Edward Marcinko MBA MEd CMP™

By Staff Reporters

***

***

The Biden administration just unveiled a plan to revamp the problem-ridden system for organ procurement and transplants.

Health Insurance: https://www.amazon.com/Dictionary-Health-Insurance-Managed-Care/dp/0826149944/ref=sr_1_4?ie=UTF8&s=books&qid=1275315485&sr=1-4

One nonprofit, United Network for Organ Sharing, has had a monopoly on running the system for nearly four decades, but the government’s proposal includes potentially bringing more organizations in, as well as upping funding and modernizing the computer systems involved.

Health Technology: https://www.amazon.com/Dictionary-Health-Information-Technology-Security/dp/0826149952/ref=sr_1_5?ie=UTF8&s=books&qid=1254413315&sr=1-5

NOTE: There are ~104,000 people currently waiting for an organ transplant, and 17 people die per day while waiting.

***

Harvesting: https://medicalexecutivepost.com/2017/09/05/on-organ-harvesting/

Dialysis: https://medicalexecutivepost.com/2021/09/22/podcasts-more-dialysis-center-investigative-reporting/

Body Brokers: https://www.msn.com/en-us/news/us/new-cbs-reports-documentary-body-brokers-explores-realities-of-donating-bodies-to-science/vi-AA18WVZ8?ocid=U521DHP&pc=U521&cvid=11f7cdab99224f1aa9290a2a3dbed05b&ei=33

COMMENTS APPRECIATED

Thank You

***

ORDER: https://www.routledge.com/Risk-Management-Liability-Insurance-and-Asset-Protection-Strategies-for/Marcinko-Hetico/p/book/9781498725989

***

Filed under: "Doctors Only", Drugs and Pharma, Ethics, Health Insurance, Health Law & Policy, iMBA, Inc., Industry Indignation Index, Information Technology, LifeStyle, Risk Management | Tagged: , , , , , , , , , | Leave a comment »

PODCASTS: More Dialysis Center Investigative Reporting

Posted on September 22, 2021 by Dr. David Edward Marcinko MBA MEd CMP™

DaVITA and FRESENIUS

By Eric Bricker MD

****

***

Your comments are appreciated.

CITE: https://www.r2library.com/Resource/Title/0826102549

MORE

***

PODCAST: The Health Economics of Renal Dialysis

Filed under: Ethics, Experts Invited, Health Economics, Health Insurance, Health Law & Policy, Healthcare Finance, Managed Care, Research & Development, Videos | Tagged: , , , , , , | 1 Comment »

PODCAST: The Health Economics of Renal Dialysis

Posted on September 3, 2021 by Dr. David Edward Marcinko MBA MEd CMP™

***

KIDNEY DIALYSIS

CITE: https://www.r2library.com/Resource/Title/0826102549

BY DR. ERIC BRICKER MD

You Comments and Thoughts are Appreciated.

THANK YOU

***

Filed under: Ethics, Experts Invited, Health Economics, Health Insurance, Health Law & Policy, Healthcare Finance | Tagged: , , , , , , , | Leave a comment »